Jason Kent

Partner
jkent@cooley.com
Full contact info

I build long-term relationships with my clients, guiding them through all stages of development, from startup to IPO and beyond.

About Jason

Jason is an experienced corporate and securities lawyer who has spent close to 25 years working with public and private companies on a wide range of transactional and counseling related matters. For his public company clients, Jason handles public offerings and other complex securities transactions, Board and corporate governance advice, SEC reporting and disclosure issues and compliance matters. In addition, Jason is an expert in venture financings, mergers and acquisitions, employment and compensation arrangements and founder and shareholder matters, and he regularly acts as the outside corporate counsel for his clients. Jason prides himself on the ability to deliver highly sophisticated advice in a pragmatic, business-oriented way that advances his clients' objectives. He is deeply committed to client service and strives to build long-term trusted relationships with the companies he represents, many of which he has worked with for well over a decade.

View full bio

Passions

Family

Fitness

Live Music

Experience

CHARM Therapeutics Secures $80 Million Series B

CHARM Therapeutics Secures $80 Million Series B

September 2, 2025

Cooley advised CHARM Therapeutics, a biotechnology company pioneering the next generation of precision oncology treatments through its proprietary artificial intelligence-driven drug discovery platform, on its $80 million Series B financing, to advance its next-generation menin inhibitor into clinical development.

Read more

Related contacts

Jason Kent
Partner, New York
Eric Blanchard
Partner, Boston
Yoon Soo (Peter) Shin
Associate, New York
Lois NaYeon Yoo
Associate, New York
Jim Fulton
Partner, New York
Stephanie Gentile
Partner, New York
Christopher Kimball
Partner, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Harriet Fraser
Associate, New York
Calvin Lee
Associate, New York
Katie Kissner
Quantitative Analyst, San Francisco

Related Practices & Industries

Emerging Companies
Biotechnology
Capital Markets
Tax
Life Sciences and Healthcare Regulatory

Chimerix Announces Acquisition by Jazz Pharmaceuticals for $935 Million

Chimerix Announces Acquisition by Jazz Pharmaceuticals for $935 Million

March 5, 2025

Cooley advised Chimerix (Nasdaq: CMRX), a biopharmaceutical company with a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, on its definitive agreement to be acquired by Jazz Pharmaceuticals (Nasdaq: JAZZ) for $8.55 per share in cash – totaling approximately $935 million.

Read more

Related contacts

Jason Kent
Partner, New York
Kevin Cooper
Partner, New York
Nathan Baum
Special Counsel, New York
Jamie Leigh
Partner, San Francisco
Izzy Lubarsky
Partner, New York
Susan Choy
Associate, New York
Charlotte Yin
Associate, New York
Angela Kim
Associate, New York
Jane Adams
Partner, San Diego
Christophe Beauduin
Partner, New York
Ross Eberly
Partner, Santa Monica
Stella Sarma
Partner, Brussels
Natasha Leskovsek
Of Counsel, Washington, DC
Juliana Finley
Associate, Santa Monica
Elizabeth Galvin
Associate, Boston
Carly E. Gibbons
Associate, Chicago
Nathaniel Hearn Jr.
Associate, Chicago
Calvin Lee
Associate, New York
Joseph Perry
Associate, Reston
Greg Reith
Associate, Washington, DC
Freddy Yip
Associate, Hong Kong
Drue Anne Koons
Paralegal Specialist, San Diego
Talya Whyte
Associate, New York

Related Practices & Industries

Mergers and Acquisitions
Capital Markets
Life Sciences
Healthcare
Life Sciences Corporate Partnering and Licensing
Life Sciences and Healthcare Regulatory
CooleyREG
Trademark, Copyright and Advertising
Tax
Labor and Employment
Compensation and Benefits
Antitrust and Competition
Debt Finance

Sazerac Agrees to Acquire BuzzBallz

Sazerac Agrees to Acquire BuzzBallz

March 20, 2024

Cooley advised Sazerac, one of the world’s largest distilled spirits companies, on its agreement to acquire BuzzBallz, a woman-owned and family-operated distillery, winery and brewery in Texas.

Read more

Related contacts

Ben Beerle
Partner, San Francisco
Amelia Runyan Davis
Partner, Colorado
Sangitha Palaniappa
Associate, Palo Alto
Queenie Chen
Associate, Palo Alto
Megan Browdie
Partner, Washington, DC
Ross Eberly
Partner, Santa Monica
Todd Gluth
Partner, San Diego
Kathleen Goodhart
Partner, San Francisco
Len Jacoby
Partner, New York
Jason Kent
Partner, New York
Barbara Mirza
Partner, Santa Monica
Howard Morse
Senior Counsel, Washington, DC
Stacey A. Bradford
Special Counsel, Washington, DC
Maricel Mojares-Moore
Special Counsel, San Francisco
Stella Sarma
Partner, Brussels
Liza Hadley
Associate, Boston
Greg Reith
Associate, Washington, DC
Patrick Sharma
Associate, Santa Monica
Rubin Waranch
Associate, Colorado
Andy Zachrich
Associate, San Francisco
Patricia Myers
Paralegal Specialist, Colorado
Chris Rhem
Paralegal Specialist, San Francisco

Related Practices & Industries

Mergers and Acquisitions
Food and Beverage
Retail and Consumer Products
Antitrust and Competition
Labor and Employment
Technology Transactions
Private Equity
Debt Finance
Tax
Compensation and Benefits
Commercial Litigation

2045 Launches and Raises 4 2 Million in PreSeed Funding

2045 Launches and Raises 4 2 Million in PreSeed Funding

June 8, 2023

New York – June 8, 2023 – Cooley advised 2045, an exclusive membership network for influential      professionals of color, on its launch and $4.2 million pre-seed financing. Partner Jason Kent led the Cooley team advising 2045.

Benchstrength led the funding round, with AAF Management and Connecticut Innovations also participating. NBA New Orleans Pelicans player CJ McCollum also participated as an angel investor.

Porter Braswell, a former Goldman Sachs alumnus, founded 2045 to provide a platform and community to empower influential professionals of color to feel seen, heard and valued. The company fills the current market void while addressing the less than 1% of the $50 billion pledged by American companies to support Black communities – and diversity, equity and inclusion efforts – following the death of George Floyd in 2020 . 2045 will provide the necessary tools and programs to help corporations better support, retain and promote a diverse workforce.

Read more

Related contacts

Jason Kent
Partner, New York
Dr. Fraser Brown
Partner, Washington, DC

Related Practices & Industries

Emerging Companies

Mirum Pharmaceuticals – $275 Million Convertible Senior Notes Offering

Mirum Pharmaceuticals – $275 Million Convertible Senior Notes Offering

April 13, 2023

Cooley advised Mirum Pharmaceuticals on its $275 million aggregate principal amount of 4.00% convertible senior notes due 2029. Mirum is a biopharmaceutical company dedicated to transforming the treatment of rare liver diseases. Jason Kent and Jason Savich led the Cooley team.

Related contacts

Jason Kent
Partner, New York
Jason Savich
Partner, San Francisco
Stevie Yu
Associate, New York
Marjorie O'Neill
Associate, San Francisco
Nicholaus E. Johnson
Associate, San Diego
Winda Fung
Associate, Santa Monica

Related Practices & Industries

Capital Markets
Life Sciences
View more

Admissions and credentials

New York

California

Massachusetts

Rankings and accolades

Chambers USA: Corporate/M&A – New York (2021 – 2025)

Memberships and affiliations

American Bar Association (ABA)

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.